STOCK MARKET

Aurobindo Pharma Ltd Down for Fifth Straight Session

The successful completion of the trial is an important step toward introducing a more affordable version.

On the National Stock Exchange (NSE), Aurobindo Pharma Ltd fell 0.9% daily. The stock slipped to 35.44% in 2021 compared to a 5.59% rally in Nifty and a 5.09% fall in the Nifty Metal index.

Aurobindo Pharma Ltd went down for a fifth straight session on December 9 2022. The stock is quoting at Rs 454.7, down 0.9% on the NSE. The benchmark Nifty is down around 0.64%, quoting 18490.6.

The Sensex is at 62,131.96, down 0.7%. Aurobindo Pharma Ltd eased around 4.83% in 2021. Meanwhile, the Nifty Metal index of which Aurobindo Pharma Ltd has reduced by about 1.71% in 2021 and recently up 0.26% on the day. The volume in the stock stood at 5.64 lakh shares on December 9, 2022, compared to the daily average of 25.9 lakh shares in September.

In the December futures contract, the benchmark for the stock is quoted at Rs 456.7, down 1.02%. Aurobindo Pharma Ltd slipped to 35.44% in 2021 compared to a 5.59% rally in Nifty and a 5.09% fall in the Nifty Metal index.

As of September’s end, the stock’s PE is 19.19 based on TTM earnings.

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



πŸ“°
News
πŸ“ˆ
Prediction
πŸ“Š
FII / DII
πŸ‘”
Advisory
Get 1-2 Index Option Trades Daily